• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1993 Fiscal Year Final Research Report Summary

Study on the induction of cytotoxic lymphocytes that act on urological tumors and its clinical application

Research Project

Project/Area Number 03454385
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Urology
Research InstitutionKYOTO UNIVERSITY

Principal Investigator

YOSHIDA Osamu  Kyoto Univesity, Faculty of Medicine, Professor, 医学部, 教授 (70025584)

Co-Investigator(Kenkyū-buntansha) MIZUTANI Youichi  Kyoto University, Faculty of Medicine, Instructor, 医学部, 助手 (10243031)
TERACHI Toshiro  Kyoto University, Faculty of Medicine, Assistant Professor, 医学部, 講師 (50207487)
HASHIMURA Takayuki  Kyoto University, Faculty of Medicine, Assistant Professor, 医学部, 講師 (40189478)
OISHI Kenji  Kyoto University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (10152042)
Project Period (FY) 1991 – 1993
KeywordsUrological tumor / Cytotoxic Lymphocyte / BCG / CK-432 / CDDP / PSK / TNF / BSO
Research Abstract

We demonstrate the following results :
1. Protein-bound polysaccharide Kreha ( PSK ) augments cytotoxic activity of peripheral blood lymphocytes ( PBL ) against urinary bladder tumor cells in vitro and in vivo in patients with urinary bladder tumor. The PSK-mediated enhancement of cytotoxicity of PBL may be largely due to an alpha-1, 4-glucan of less than 50 kd.
2. Bacillus Calmette-Guerin ( BCG ) activates the tumor killing system through stimulation of effector cells and elevation of target cell susceptibility to lysis by cytotoxic lymphocytes in patients with urinary bladder tumor. Furthermore, BCG-augmented cytotoxicity may be specifically oriented to urinary bladder tumor cells.
3. Combination treatment of MBT-2 murine urinary bladder tumor cell line transplanted into C3H/He mice with BCG and exogenous fibrinogen prolongs accumulation of BCG by trapping BCG in fibrin meshwork, and induces marked infiltration of inflammatory cells into tumor stroma, causing marked regression of the tu … More mor.
4. Like BCG, OK-432 activates the autologous tumor killing system through stimulation of effector cells and enhancement of target cell susceptibility to lysis by effector cells in patients with urinary bladder tumor. Moreover, the OK-432-augmented target sensitivity to lysis by cytotoxic lymphocytes may be oriented specifically to urinary bladder tumor cells.
5. Cis-diamminedichloroplatinum ( II ) ( CDDP ) has an augmenting effect on the susceptibility of urinary bladder tumor cells to the cell-mediated cytotoxicity partly through a modification of cell membrane and inhibition of DNA synthesis.
6. Cytotoxic lymphocytes activated by tumor cells produce various kinds of cytokines such as tumor necrosis factor-alpha ( TNF-alpha ) which exert cytotoxic activity against tumor cells. TNF-alpha in combination with CDDP, buthionine sulfoximine ( BSO ) or pentoxifylline ( PTX ) overcomes the TNF-alpha-resistance of renal cell carcinoma cells. Downregulation of TNF-alpha mRNA by CDDP, BSO or PTX may play a role in the enhanced cytotoxicity seen with TNF-alpha in combination with CDDP, BSO or PTX. Less

  • Research Products

    (56 results)

All Other

All Publications (56 results)

  • [Publications] Youichi Mizutani: "Activation by the protein-bound polysaccharide PSK (Krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer." The Journal of Urology. 145. 1082-1087 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Akihiro Krishita: "Post-radiation treatment with OK-432 can prevent radiation induced bone marrow death." International Journal of Radiation Biology. 59. 711-716 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Thoshiro Terachi: "Coexistence of autologous antibodies and decay accelerating factor,an inhibitor of complement,on human renal tumor cells." Cancer Research. 51. 2521-2523 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shunitsu Kaku: "Impared interferon-α production in whole-blood cultures from bladder cancer patients." Urological Research. 19. 51-56 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 吉田 修: "腎癌に対する天然型インターフェロンα(HLBI)による術後補助療法の検討" BIOTHERAPY. 6. 1127-1135 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 新島 端夫: "腎細胞癌に対する天然型ヒト腫瘍壊死因子(MHR-24)と天然型インターフェロン-α(MOR)の併用瞭法" 泌尿器科紀要. 38. 1201-1207 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients urinary bladder cancer." CANCER. 69. 537-545 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to the autologous peripheral blood lymphocytes." CANCER. 69. 2999-3007 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Modulation by cis-diamminedichloroplatinum(II)(CDDP)of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to blood natural killer(NK)cells and lymphokine activated killer(LAK)cells." The Journal of Urology. 147. 505-510 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells." The Journal of Urology. 148. 1571-1576 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells." CANCER. 71. 1313-1321 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Overcoming CDDP resistance of human ovarian tumor cells by combination treatment with CDDP and TNF-α." CANCER. 72. 809-818 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Overcoming TNF-α and CDDP resistance of a human ovarian cancer cell line(C30)by treatment with buthionine sulfoximine in combination with TNF-α and/or CDDP." International Journal of Oncology. 3. 229-235 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水谷 陽一: "膀胱腫瘍患者末梢血リンパ球のヒトT24膀胱移行上皮癌株化細胞と新鮮自己腫瘍細胞に対する細胞傷害活性に及ぼすBCGの影響" BIOTHERAPY. 7. 317-318 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 寺地 敏郎: "Interferon-α,UFT併用療法により腎癌多発転移巣が長期完全寛解を示した1例" 泌尿器科紀要. 39. 353-355 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 橋村 孝幸: "膀胱癌細胞へのIFN-γ遺伝子導入による癌免疫療法" 泌尿器科紀要. 39. 1205-1208 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 吉田 修: "臨床医学の展望-診断及び治療上の進歩:泌尿器科:臨床免疫学" 医事新報. 3644. 46-47 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水谷 陽一: "BCG,フィブリノーゲン混合投与によるBCG局所療法の抗腫瘍効果の増強" BIOTHERAPY. (発表予定). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Overcoming TNF-α resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and TNF-α." CANCER. 73. 730-737 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Enhanced antitumor effect of bacillus Calmette-Guerin in combionation with fibrinogen on urinary bladder tumor." The Journal of Urology. 151 (発表予定). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Overcoming TNF-α and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-α or drugs." The Journal of Urology. 151 (発表予定). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "In vitro enhancement of natural killer cell activity by BCG and the antagonistic inhibition of the susceptibility of K562 cells to lysis by peripheral blood lymphocytes in patients with urinary bladder tumor." International Journal of Urology. 1 (発表予定). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Enhanced sensitivity of a human ovarian cancer cell line(OVC-8)to TNF-α by pentoxifylline." Biotherapy. (発表予定). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Masaru Hiura: "Induction of specific anti-tumor immunity by interferon-γ gene-transplanted murine bladder carcinoma MBT-2" Folia Biologica. 40 (発表予定). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "Frontiers of Hucosal Immunology" Excerpta Medica, 2 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Benjamin Bonarida: "Immunomodulation" Express Tirages, 10 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Youichi Mizutani: "The Year Book of UROLOGY 1993" Mosby, 2 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水谷 陽一: "第11回泌尿器科漢方研究会講演集" 現代出版株式会社 (発表予定), (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mizutani, Y.and Yoshida, O.: "Activation by the protein-bound polysaccharide PSK ( Krestin ) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer." The Journal of Urology. 145. 1082-1087 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y.and Yoshida, O.: "Effect of a protein-bound polysaccharide PSK ( Krestin ) on natural killer ( NK ) activity and autotumor killing ( ATK ) activity in vivo and in vitro in patients with urinary bladder tumor. In : Frontiers of Mucosal Immunology. Volume 2. Edited by M.Tsuchiya, H.Nagura, H.Hibi and I.Moro.Amsterdam :" Excerpta Medica. 477-478 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kurishita, A., Katoh, H., Uehara, Y., Uchida, A., Mizutani, Y., Ono, T., Hirose, S.and Okada, S.: "Post-radiation treatment with OK-432 can prevent radiation induced bone marrow death." International Journal of Radiation Biology. 59. 711-716 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Terachi, T., Stanescu, G., Pontes, J.E., Medof, M.E.and Caulfied, J.: "Coexistence of autologous antibodies and decay accelerating factor, an inhibitor of complement, on human renal tumor cells." Cancer Research. 51. 2521-2523 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kuo, J.Y., Nishio, Y., Kanamaru, H., Okada, Y., Kita, M., Imanishi, J., Kishida, T.and Yoshida, O.: "Impaired interferon-alpha production in whole-blood cultures from bladder cancer patients." Urological Research. 19. 51-56 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., Nio, Y., Fukumoto, M.and Yoshida, O.: "Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients urinary bladder cancer." CANCER. 69. 537-545 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., Nio, Y.and Yoshida, O.: "The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to the autologous peripheral blood lymphocytes." CANCER. 69. 2999-3007 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., Nio, Y.and Yoshida, O.: "Modulation by cis-diamminedichloroplatinum ( II ) ( CDDP ) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to blood natural killer ( NK ) cells and lymphokine activated killer ( LAK ) cells." The Journal of Urology. 147. 505-510 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., Nio, Y.and Yoshida, O.: "Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells." The Journal of Urology. 148. 1571-1576 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Bonavida, B., Berek, J., Safrit, J., Mizutani, Y.and Morimoto, H.: "Activite synergique du TNF et des drogues ou toxines cytotoxiques sur leslignees tumorales in vitro. IN : L'Immunomodulation. Edited by S.Chouaib and J.M.Mencia-Huerta. France :" Express Tirages. 169-178 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshida, O., Terachi, T., Tomoyoshi, T., Kawamura, J., Okada, K., Usui, T.and Yamamoto, N.: "Adjuvant therapy with natural human interferon-alpha (HLBI) for renal cell carcinoma." BIOTHERAPY. 6. 1127-1135 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Niijima, T., Yoshida, O., et al.: "Combination therapy with natural type human tumor necrosis factor ( MHR-24 ) and human lymphoblastoid interferon-alpha ( MOR-22 ) against renal cell carcinoma." Acta Urologica Japonica. 38. 1201-1207 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., Nio, Y., Bonavida, B.and Yoshida, O.: "Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells." CANCER. 71. 1313-1321 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y.and Bonavida, B.: "Overcoming CDDP resistance of human ovarian tumor cells by combination treatment with CDDP and TNF-alpha." CANCER. 72. 809-818 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y.and Bonavida, B.: "Overcoming TNF-alpha and CDDP resistance of a human ovarian cancer cell line (C30) by treatment with buthionine sulfoximine in combination with TNF-alpha and/or CDDP." International Journal of Oncology. 3. 229-235 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., Nio, Y., Fukumoto, M.and Yoshida, O.: "Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients urinary bladder cancer. IN : The Year Book of Urology 1993.Edited by J.Y.Gillenwater and S.S.Howards. St.Louis :" Mosby. 109-110 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y.and Yoshida, O.: "Effect of BCG on cytotoxic activity of peripheral blood lymphocytes against human T24 line and freshly isolated autologous urinary bladder transitional carcinoma cells in patients urinary bladder cancer." BIOTHERAPY. 7. 317-318 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Terachi, T., Okada, Y., Takeuchi, H.and Yoshida, O.: "Long-term complete response of multiple lung metastasis from renal cell carcinoma induced by combination therapy with interferon-alpha and UFT :" a case report. Acta Urologica Japonica. 39. 353-355 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hashimura, T., Hiura, M., Yoshida, O., Teramura, Y., Kuribayashi, K., and Watanabe, Y.: "Cancer immunotherapy by murine bladder cancer cells transfected withmouse IFN-gamma gene." Acta Urologica Japonica. 39. 1205-1208 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y.and Yoshida, O.: "Overcoming TNF-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and TNF-alpha. Role of TNF-alpha mRNA downregulation in tumor cell sensitization." CANCER. 73. 730-737 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., Nio, Y., Fukumoto, M.and Yoshida, O.: "Enhanced antitumor effect of bacillus Calmette-Guerin in combination with fibrinogen on urinary bladder tumor." The Journal of Urology. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., Bonavida, B., Nio, Y.and Yoshida, O.: "Overcoming TNF-alpha and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-alpha or drugs." The Journal of Urology. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., and Yoshida, O.: "In vitro enhancement of natural killer cell activity by BCG and the antagonistic inhibition of the susceptibility of K562 cells to lysis by peripheral blood lymphocytes in patients with urinary bladder tumor." International Journal of Urology. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y.and Bonavida, B.: "Enhanced sensitivity of a human ovarian cancer cell line ( OVC-8 ) to TNF-alpha by pentoxifylline." Biotherapy. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y., Nio, Y., Fukumoto, M.and Yoshida, O.: "Augmentation of antitumor activity against urinary bladder tumor by combination treatment with BCG and fibrinogen." BIOTHERAPY. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshida, O.: "The view of clinical medicine. Urology.Clinical immunology." Japan Medical Journal. 3644. 46-47 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizutani, Y.and Yoshida, O.: "Effect of PSK and its subfractions on the cytotoxic activity of peripheral blood lymphocytes against urinary bladder tumor cells in patients with urinary bladder tumor. In : Proceeding of 11th conference of urological Kanpo research. Tokyo :" Gendai Shuppan Co.Ltd.(in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hiura, M., Hashimura, T., Watanabe, Y., Kuribayashi, K.and Yoshida, O.: "Induction of specific anti-tumor immunity by interferon-g gene-transfected murine bladder carcinoma MBT-2." Folia Biologica. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1995-03-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi